Head-to-head · Cost-Efficiency Index
PepHaūs vs Ro
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
PepHaūs
People who want a verified all-50 program with both molecules disclosed and will pay mid-market for the peace of mind.
Visit PepHaūsRo
People who need brand-name (Wegovy/Zepbound) access or insurance navigation and will accept price opacity for it.
Visit RoThe verdict
PepHaūs takes it, leading the Cost-Efficiency Index 85 to 84. Mid-market $152/$246 pricing on both molecules, all-50 and LegitScript-verified — a clean, verified nationwide option that trades rock-bottom cost for a dependable pharmacy. Ro still earns a B — People who need brand-name (Wegovy/Zepbound) access or insurance navigation and will accept price opacity for it.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs PepHaūs.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | PepHaūs | Ro |
|---|---|---|
| Cost-Efficiency Index | 85/100 | 84/100 |
| Semaglutide / mo | $152/mo | Not disclosed (drug); $149/mo Ro Body membership separately |
| Tirzepatide / mo | $246/mo | Not disclosed (drug); $149/mo Ro Body membership separately |
| Semaglutide / yr (modeled) | $1,824 | — |
| Tirzepatide / yr (modeled) | $2,952 | — |
| Coverage | All 50 states | Multi-state |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #18 | #20 |
PepHaūs
85/100Where the value is
- Both molecules disclosed at flat prices with nationwide all-50 access
- LegitScript-certified pharmacy behind the program
- Predictable pricing that's straightforward to model for a year
The tradeoffs
- $152/$246 is mid-market — undercut on raw cost by several verified all-50 rivals
- Compounded only — no brand-name or oral option
Ro
84/100Where the value is
- Brand-name access and a dedicated insurance concierge to help navigate drug coverage
- Oral options (including the newer Foundayo/orforglipron pill) widen the formulary
- Named, credentialed Chief Medical Officer (Dr. Melynda Barnes, MD) and a public LegitScript certificate (#3722005)
The tradeoffs
- Does not publish compounded pricing up front — a blind spot in any cost model
- The $74/mo membership figure often quoted requires a full year prepaid upfront; month-to-month membership billing is $149/mo, and the drug cost is a separate charge on top of either
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.